Skip to main content
. 2022 Jan 19;6:100133. doi: 10.1016/j.prdoa.2022.100133

Table 2.

Distribution of study characteristics for the primary outcome.

Number of studies
PD model
6-OHDA 3
MPTP 5
Rotenone 2
GLP-1 receptor agonist intervention Liraglutide 8
Exenatide/exendin-4 3
Semaglutide 2
Lixisenatide 1
Outcome TH + neurons in the SNpc 6
Striatal dopamine content 2
TH + density in the SNpc 2